About Charles Hudson
Charles Hudson is the founder and managing partner of Precursor Ventures, one of the most respected Bay Area pre-seed firms, with a long track record of writing first checks across consumer, B2B, and (increasingly) digital health. Healthcare is a meaningful but not dominant slice of the portfolio; the pattern is digital health and healthcare software at pre-seed and seed, $100k-$250k checks. AI focus not flagged as primary. San Francisco-based, US scope. Best fit: pre-seed and seed founders, especially first-time and underrepresented founders, building software-led digital health or healthcare software where Precursor’s brand and network create real follow-on signal; founders who want a thoughtful, principled early lead rather than a rolling solo check. Entry path is the Precursor website (they take inbound seriously and Hudson has historically responded to good cold pitches) and warm intros via Precursor portfolio founders or the Bay Area pre-seed ecosystem. Not a fit for biotech, devices, life sciences tools, or US-payer-heavy enterprise health plays that need a deeply specialized partner. Expect a careful, founder-first conversation; Hudson’s reputation for honesty and thoughtfulness with founders is well-earned, and that is the value-add.
Founder reviews
Pitch / review this investor
Have you raised from Charles Hudson? Founders only — share your honest experience (anonymous OK, moderated before publishing).